Table 2 Obstetric and neonatal outcomes of the groups
From: The role of incretins in gestational diabetes: a case-control study on the impact of obesity
| Â | Obese GDM n:24 | Non-Obese GDM n:24 | Obese Non-GDM n:24 | Non-Obese Non-GDM n:24 | P |
|---|---|---|---|---|---|
Use of Insulin | 10 (41.7) | 1 (9.1) | 0 (0) | 0 (0) | < 0.001 |
Diet | 14 (58.3) | 22 (95.7) | 0 (0) | 0 (0) | < 0.001 |
Hypothyroidism | 0 (0) | 0 (0) | 2 (10) | 0 (0) | 0.456 |
Route of Delivery Cesarean Vaginal Birth | 20 (83.3) 4 (16.7) | 17 (73.9) 6 (26.1) | 18 (90) 2 (10) | 13 (65) 7 (35) | 0.340 |
Indications of Cesarean Abrubtion Gestational Hypertension Malpresentation Previous cesarean CPD Fetal distress Macrosomia Preeclampsia | 1 (5) 4 (20) 1 (5) 8 (40) 5 (25) 1 (5) 0 (0) 0 (0) | 0 (0) 0 (0) 2 (11.8) 10 (58.8) 3 (17.6) 0 (0) 1 (5.9) 1 (5.9) | 0 (0) 0 (0) 2 (11.1) 6 (33.3) 9 (50) 0 (0) 0 (0) 1 (5.6) | 0 (0) 0 (0) 0 (0) 7 (53.8) 3 (23.1) 0 (0) 0 (0) 1 (7.7) | 0.012 |
Preterm labour | 5 (20.8) | 1 (4.3) | 1 (5) | 1 (5) | 0.080 |
Neonatal Weight | 3300(2080–4010) | 3265 (2200–4805) | 3345 (2310–3970) | 3242 (2180–3885) | 0.685 |
APGAR-I | 8 (7–9) | 8 (6–10) | 9 (7–10) | 9 (7–9) | 0.001 |
APGAR 5 | 10 (9–10) | 9 (7–10) | 10 (9–10) | 10 (9–10) | 0.003 |
IUGR | 1 (4.2) | 0 (0) | 1 (5) | 1 (5) | 0.692 |
Oligohydramnios | 0 (0) | 1 (4.3) | 0 (0) | 0 (0) | 0.712 |
Polyhydramnios | 3 (12.5) | 2 (8.7) | 0 (0) | 0 (0) | 0.038 |
NICU | 9 (37.5) | 11 (47.8) | 2 (10) | 1 (20) | 0.002 |